These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 11280862
1. [Lymphatic involvement in non-small cell bronchial cancer: surgical and prognostic implications]. Riquet M, Manac'h D, Dujon A. Rev Pneumol Clin; 2000 Oct; Suppl 2():18-20. PubMed ID: 11280862 [No Abstract] [Full Text] [Related]
2. [Capsular rupture of N2 resected lymph nodes and surgery of bronchial cancer]. Riquet M. Rev Mal Respir; 1996 Dec; 13(6):535-7. PubMed ID: 9036497 [No Abstract] [Full Text] [Related]
3. [Result of surgical treatment to early stage peripheral non-small cell lung cancer]. Yoneda S, Okabayashi K, Kawahara K, Iwazaki A, Yoshinaga Y, Yamamoto S, Ikeda K, Hamatake D, Takahashi M, Katoh F, Hayashi H, Yamaguchi R, Yoshida Y, Shirakusa T. Kyobu Geka; 2001 Oct; 54(11):932-7. PubMed ID: 11593730 [Abstract] [Full Text] [Related]
4. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP. Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424 [Abstract] [Full Text] [Related]
5. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y. Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383 [Abstract] [Full Text] [Related]
6. [Surgical treatment for stage III N2 non-small cell lung cancer]. Wang S, Wu Y, Rong T, Huang Z, Ou W. Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):605-7. PubMed ID: 12667337 [Abstract] [Full Text] [Related]
7. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, Hölscher AH. J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010 [Abstract] [Full Text] [Related]
8. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system. Shimada Y, Tsuboi M, Saji H, Miyajima K, Usuda J, Uchida O, Kajiwara N, Ohira T, Hirano T, Kato H, Ikeda N. Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116 [Abstract] [Full Text] [Related]
9. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer. Nakagawa T, Okumura N, Kokado Y, Miyoshi K, Matsuoka T, Kameyama K. Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):474-8. PubMed ID: 17669909 [Abstract] [Full Text] [Related]
10. [Surgical treatment for adrenal metastasis from lung cancer]. Itou S, Imai T, Usami N, Uchiyama M, Yasuda A, Kawaguchi K, Yokoi K. Kyobu Geka; 2006 Jan; 59(1):47-52. PubMed ID: 16440685 [Abstract] [Full Text] [Related]
11. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis. Wisnivesky JP, Henschke C, McGinn T, Iannuzzi MC. Lung Cancer; 2005 Aug; 49(2):181-6. PubMed ID: 16022911 [Abstract] [Full Text] [Related]
12. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Rea F, Marulli G, Callegaro D, Zuin A, Gobbi T, Loy M, Sartori F. Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193 [Abstract] [Full Text] [Related]
13. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Demir A, Turna A, Kocaturk C, Gunluoglu MZ, Aydogmus U, Urer N, Bedirhan MA, Gurses A, Dincer SI. Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121 [Abstract] [Full Text] [Related]
14. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. Inoue M, Minami M, Shiono H, Sawabata N, Ideguchi K, Okumura M. J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580 [Abstract] [Full Text] [Related]
15. [Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer]. Wang S, Wu Y, Ou W. Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):259-61. PubMed ID: 11783103 [Abstract] [Full Text] [Related]
16. Postrecurrence survival in patients with stage I non-small cell lung cancer. Nakagawa T, Okumura N, Ohata K, Igai H, Matsuoka T, Kameyama K. Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404 [Abstract] [Full Text] [Related]
17. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy. Varlotto JM, Flickinger JC, Recht A, Nikolov MC, DeCamp MM. Cancer; 2008 Apr 01; 112(7):1547-54. PubMed ID: 18260087 [Abstract] [Full Text] [Related]
18. Subcategorization of resectable non-small cell lung cancer involving neighboring structures. Sakakura N, Mori S, Ishiguro F, Fukui T, Hatooka S, Shinoda M, Yokoi K, Mitsudomi T. Ann Thorac Surg; 2008 Oct 01; 86(4):1076-83; discussion 1083. PubMed ID: 18805135 [Abstract] [Full Text] [Related]
19. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma. Iizasa T, Suzuki M, Yasufuku K, Iyoda A, Otsuji M, Yoshida S, Sekine Y, Shibuya K, Saitoh Y, Hiroshima K, Fujisawa T. Ann Thorac Surg; 2004 Jun 01; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232 [Abstract] [Full Text] [Related]
20. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease. Hsu CP, Hsia JY, Chang GC, Chuang CY, Shai SE, Yang SS, Lee MC, Kwan PC. J Thorac Cardiovasc Surg; 2009 Aug 01; 138(2):426-33. PubMed ID: 19619791 [Abstract] [Full Text] [Related] Page: [Next] [New Search]